Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Mol Cell ; 70(4): 650-662.e8, 2018 05 17.
Article in English | MEDLINE | ID: mdl-29731414

ABSTRACT

Class switch recombination (CSR) at the immunoglobulin heavy-chain (IgH) locus is associated with the formation of R-loop structures over switch (S) regions. While these often occur co-transcriptionally between nascent RNA and template DNA, we now show that they also form as part of a post-transcriptional mechanism targeting AID to IgH S-regions. This depends on the RNA helicase DDX1 that is also required for CSR inĀ vivo. DDX1 binds to G-quadruplex (G4) structures present in intronic switch transcripts and converts them into S-region R-loops.Ā This in turn targets the cytidine deaminase enzyme AID to S-regions so promoting CSR. Notably R-loop levels over S-regions are diminished by chemical stabilization of G4 RNA or by the expression of a DDX1 ATPase-deficient mutant that acts as a dominant-negative protein to reduce CSR efficiency. In effect, we provide evidence for how S-region transcripts interconvert between G4 and R-loop structures to promote CSR in the IgH locus.


Subject(s)
Adenosine Triphosphatases/metabolism , DEAD-box RNA Helicases/physiology , G-Quadruplexes , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Switch Region/genetics , RNA/chemistry , Adenosine Triphosphatases/genetics , Animals , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Cytidine Deaminase/genetics , Cytidine Deaminase/metabolism , DNA Replication , Immunoglobulin Class Switching , Immunoglobulin Heavy Chains/chemistry , Immunoglobulin Heavy Chains/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA/genetics , Recombination, Genetic
2.
PLoS Pathog ; 14(5): e1006986, 2018 05.
Article in English | MEDLINE | ID: mdl-29746590

ABSTRACT

Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a major vaccine design goal, but may be hindered by conformational instability within viral envelope glycoproteins (Env). Chemical cross-linking is widely used for vaccine antigen stabilization, but how this process affects structure, antigenicity and immunogenicity is poorly understood and its use remains entirely empirical. We have solved the first cryo-EM structure of a cross-linked vaccine antigen. The 4.2 ƅ structure of HIV-1 BG505 SOSIP soluble recombinant Env in complex with a CD4 binding site-specific broadly neutralizing antibody (bNAb) Fab fragment reveals how cross-linking affects key properties of the trimer. We observed density corresponding to highly specific glutaraldehyde (GLA) cross-links between gp120 monomers at the trimer apex and between gp120 and gp41 at the trimer interface that had strikingly little impact on overall trimer conformation, but critically enhanced trimer stability and improved Env antigenicity. Cross-links were also observed within gp120 at sites associated with the N241/N289 glycan hole that locally modified trimer antigenicity. In immunogenicity studies, the neutralizing antibody response to cross-linked trimers showed modest but significantly greater breadth against a global panel of difficult-to-neutralize Tier-2 heterologous viruses. Moreover, the specificity of autologous Tier-2 neutralization was modified away from the N241/N289 glycan hole, implying a novel specificity. Finally, we have investigated for the first time T helper cell responses to next-generation soluble trimers, and report on vaccine-relevant immunodominant responses to epitopes within BG505 that are modified by cross-linking. Elucidation of the structural correlates of a cross-linked viral glycoprotein will allow more rational use of this methodology for vaccine design, and reveals a strategy with promise for eliciting neutralizing antibodies needed for an effective HIV-1 vaccine.


Subject(s)
HIV-1/chemistry , HIV-1/immunology , env Gene Products, Human Immunodeficiency Virus/chemistry , env Gene Products, Human Immunodeficiency Virus/immunology , AIDS Vaccines/chemistry , AIDS Vaccines/immunology , Animals , Antibodies, Neutralizing/immunology , Antibody Specificity , Antigen-Antibody Reactions/immunology , Cross-Linking Reagents , Cryoelectron Microscopy , HIV Antibodies/immunology , HIV Antigens/chemistry , HIV Antigens/immunology , HIV Antigens/ultrastructure , Host-Pathogen Interactions/immunology , Humans , Immunodominant Epitopes/chemistry , Immunodominant Epitopes/immunology , Mice , Mice, Inbred BALB C , Models, Molecular , Protein Conformation , Protein Stability , Protein Structure, Quaternary , Rabbits , T-Lymphocytes, Helper-Inducer/immunology , Vaccines, Synthetic/chemistry , Vaccines, Synthetic/immunology , env Gene Products, Human Immunodeficiency Virus/ultrastructure
3.
J Allergy Clin Immunol ; 133(5): 1390-9, 1399.e1-6, 2014 May.
Article in English | MEDLINE | ID: mdl-24560412

ABSTRACT

BACKGROUND: Exposure to food allergens through a disrupted skin barrier has been recognized as a potential factor in the increasing prevalence of food allergy. OBJECTIVE: We sought to test the immunologic mechanisms by which epicutaneous sensitization to food allergens predisposes to intestinal food allergy. METHODS: Mice were epicutaneously sensitized with ovalbumin or peanut on an atopic dermatitis-like skin lesion, followed by intragastric antigen challenge. Antigen-specific serum IgE levels and T(H)2 cytokine responses were measured by ELISA. Expression of type 2 cytokines and mast cell proteases in the intestine were measured by using real-time PCR. Accumulation of basophils in the skin and mast cells in the intestine was examined by using flow cytometry. In vivo basophil depletion was achieved by using diphtheria toxin treatment of Baso-DTR mice. For cell-transfer studies, the basophil population was expanded in vivo by means of hydrodynamic tail vein injection of thymic stromal lymphopoietin (TSLP) cDNA plasmid. RESULTS: Sensitization to food allergens through an atopic dermatitis-like skin lesion is associated with an expansion of TSLP-elicited basophils in the skin that promote antigen-specific T(H)2 cytokine responses, increased antigen-specific serum IgE levels, and accumulation of mast cells in the intestine, promoting the development of intestinal food allergy. Critically, disruption of TSLP responses or depletion of basophils reduced the susceptibility to intestinal food allergy, whereas transfer of TSLP-elicited basophils into intact skin promoted disease. CONCLUSION: Epicutaneous sensitization on a disrupted skin barrier is associated with accumulation of TSLP-elicited basophils, which are necessary and sufficient to promote antigen-induced intestinal food allergy.


Subject(s)
Allergens/immunology , Basophils/immunology , Cytokines/immunology , Dermatitis, Atopic/immunology , Food Hypersensitivity/immunology , Intestines/immunology , Animals , Basophils/pathology , Cytokines/genetics , Dermatitis, Atopic/complications , Dermatitis, Atopic/genetics , Dermatitis, Atopic/pathology , Food Hypersensitivity/etiology , Food Hypersensitivity/genetics , Food Hypersensitivity/pathology , Immunoglobulin E/genetics , Immunoglobulin E/immunology , Intestinal Mucosa/metabolism , Mast Cells/immunology , Mast Cells/pathology , Mice , Mice, Inbred BALB C , Mice, Knockout , Skin/immunology , Skin/pathology , Th2 Cells/immunology , Th2 Cells/pathology , Thymic Stromal Lymphopoietin
4.
J Immunol ; 187(4): 1626-33, 2011 Aug 15.
Article in English | MEDLINE | ID: mdl-21742965

ABSTRACT

Oxidative stress is widespread and entwined with pathological processes, yet its linkage to adaptive immunity remains elusive. Reactive carbonyl (RC) adduction, a common feature of oxidative stress, has been shown to target proteins to the adaptive immune system. Because aldehydes are important mediators of carbonylation, we explored the immunomodulatory properties of model Ags modified by common bioactive aldehyde by-products of oxidative stress: 4-hydroxy-2-nonenal, malondialdehyde, and glycolaldehyde. Ag modification with all three aldehydes resulted in Ag-specific IgG1-dominated responses in adjuvant-free murine immunizations in an RC-dependent manner. The central role of RCs was confirmed, as their reduction into nonreactive groups abrogated all adaptive responses, despite the presence of other well-known aldehyde-driven adducts such as N(ƎĀµ)-carboxymethyllysine and glycolaldehyde-pyridine. Moreover, Ag-specific Ab responses robustly correlated with the extent of RC adduction, regardless of the means of their generation. T cell responses mirrored the Th2-biased Ab isotypes by Ag-specific splenocyte production of IL-4, IL-5, and IL-13, but not IFN-ƎĀ³. The RC-induced Th2 response was in sharp contrast to that induced by Th1/Th2 balanced or Th1-biasing adjuvants and was maintained in a range of mouse strains. In vitro studies revealed that RC adduction enhanced Ag presentation with Th2 polarization in the absence of conventional dendritic cell activation. Taken together, these data implicate commonly occurring RC as an important oxidation-derived Th2 immunomodulatory damage-associated molecular pattern with potentially important roles in health and disease.


Subject(s)
Aldehydes/immunology , Antigens/immunology , Oxidative Stress/immunology , Th2 Cells/immunology , Aldehydes/metabolism , Animals , Antigens/metabolism , Cytokines/immunology , Cytokines/metabolism , Immunoglobulin G/immunology , Immunoglobulin G/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred CBA , Mice, SCID , Th1 Cells/immunology , Th1 Cells/metabolism , Th2 Cells/metabolism
6.
Vaccine ; 34(19): 2188-96, 2016 Apr 27.
Article in English | MEDLINE | ID: mdl-27005810

ABSTRACT

Carbopol is a polyanionic carbomer used in man for topical application and drug delivery purposes. However parenteral administration of Carbopol in animal models results in systemic adjuvant activity including strong pro-inflammatory type-1 T-cell (Th1) polarization. Here we investigated potential pathways of immune activation by Carbopol by comparison with other well-characterized adjuvants. Carbopol administration triggered rapid and robust leukocyte recruitment, pro-inflammatory cytokine secretion and antigen capture largely by inflammatory monocytes. The induction of antigen specific Th1 cells by Carbopol was found to occur via a non-canonical pathway, independent of MyD88/TRIF signaling and in the absence of pattern-recognition-receptor (PRR) activation typically associated with Th1/Ig2a induction. Using multispectral fluorescence imaging (Imagestream) and electron microscopy we demonstrated that phagocytic uptake of Carbopol particles followed by entry into the phagosomal/lysosomal pathway elicited conformational changes to the polymer and reactive oxygen species (ROS) production. We therefore conclude that Carbopol may mediate its adjuvant activity via novel mechanisms of antigen presenting cell activation and Th1 induction, leading to enhanced IgG2a responses independent of microbial pattern recognition.


Subject(s)
Acrylic Resins/pharmacology , Adaptive Immunity , Adjuvants, Immunologic/pharmacology , Inflammation/immunology , Pathogen-Associated Molecular Pattern Molecules , Animals , Antigen-Presenting Cells/immunology , Cell Line , Chemokines/immunology , Cytokines/immunology , Humans , Immunoglobulin G , Mice, 129 Strain , Mice, Inbred BALB C , Mice, Inbred C57BL , Phagocytosis , Th1 Cells/immunology
7.
Elife ; 5: e12444, 2016 Feb 24.
Article in English | MEDLINE | ID: mdl-26910010

ABSTRACT

A polymorphism in the autophagy gene Atg16l1 is associated with susceptibility to inflammatory bowel disease (IBD); however, it remains unclear how autophagy contributes to intestinal immune homeostasis. Here, we demonstrate that autophagy is essential for maintenance of balanced CD4(+) T cell responses in the intestine. Selective deletion of Atg16l1 in T cells in mice resulted in spontaneous intestinal inflammation that was characterized by aberrant type 2 responses to dietary and microbiota antigens, and by a loss of Foxp3(+) Treg cells. Specific ablation of Atg16l1 in Foxp3(+) Treg cells in mice demonstrated that autophagy directly promotes their survival and metabolic adaptation in the intestine. Moreover, we also identify an unexpected role for autophagy in directly limiting mucosal TH2 cell expansion. These findings provide new insights into the reciprocal control of distinct intestinal TH cell responses by autophagy, with important implications for understanding and treatment of chronic inflammatory disorders.


Subject(s)
Carrier Proteins/metabolism , Inflammatory Bowel Diseases/pathology , T-Lymphocytes, Regulatory/immunology , Th2 Cells/immunology , Animals , Autophagy-Related Proteins , Carrier Proteins/genetics , Gene Deletion , Mice , Mice, Knockout
8.
Clin Vaccine Immunol ; 22(9): 1004-12, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26135973

ABSTRACT

The continued discovery and development of adjuvants for vaccine formulation are important to safely increase potency and/or reduce the antigen doses of existing vaccines and tailor the adaptive immune response to newly developed vaccines. Adjuplex is a novel adjuvant platform based on a purified lecithin and carbomer homopolymer. Here, we analyzed the adjuvant activity of Adjuplex in mice for the soluble hemagglutinin (HA) glycoprotein of influenza A virus. The titration of Adjuplex revealed an optimal dose of 1% for immunogenicity, eliciting high titers of HA-specific IgG but inducing no significant weight loss. At this dose, Adjuplex completely protected mice from an otherwise lethal influenza virus challenge and was at least as effective as the adjuvants monophosphoryl lipid A (MPL) and alum in preventing disease. Adjuplex elicited balanced Th1-/Th2-type immune responses with accompanying cytokines and triggered antigen-specific CD8(+) T-cell proliferation. The use of the peritoneal inflammation model revealed that Adjuplex recruited dendritic cells (DCs), monocytes, and neutrophils in the context of innate cytokine and chemokine secretion. Adjuplex neither triggered classical maturation of DCs nor activated a pathogen recognition receptor (PRR)-expressing NF-κB reporter cell line, suggesting a mechanism of action different from that reported for classical pathogen-associated molecular pattern (PAMP)-activated innate immunity. Taken together, these data reveal Adjuplex to be a potent and well-tolerated adjuvant with application for subunit vaccines.


Subject(s)
Adaptive Immunity , Adjuvants, Immunologic , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Influenza A Virus, H1N1 Subtype/immunology , Influenza Vaccines/immunology , Orthomyxoviridae Infections/prevention & control , Acrylic Resins , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Viral/biosynthesis , Antibodies, Viral/immunology , B-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/immunology , Influenza Vaccines/administration & dosage , Lecithins/immunology , Mice, Inbred BALB C , Orthomyxoviridae Infections/immunology , Pathogen-Associated Molecular Pattern Molecules , Th1-Th2 Balance , Vaccination
9.
Nat Med ; 19(8): 1005-13, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23872715

ABSTRACT

Eosinophilic esophagitis (EoE) is a food allergy-associated inflammatory disease characterized by esophageal eosinophilia. Current management strategies for EoE are nonspecific, and thus there is a need to identify specific immunological pathways that could be targeted to treat this disease. EoE is associated with polymorphisms in the gene that encodes thymic stromal lymphopoietin (TSLP), a cytokine that promotes allergic inflammation, but how TSLP might contribute to EoE disease pathogenesis has been unclear. Here, we describe a new mouse model of EoE-like disease that developed independently of IgE, but was dependent on TSLP and basophils, as targeting TSLP or basophils during the sensitization phase limited disease. Notably, therapeutic TSLP neutralization or basophil depletion also ameliorated established EoE-like disease. In human subjects with EoE, we observed elevated TSLP expression and exaggerated basophil responses in esophageal biopsies, and a gain-of-function TSLP polymorphism was associated with increased basophil responses in patients with EoE. Together, these data suggest that the TSLP-basophil axis contributes to the pathogenesis of EoE and could be therapeutically targeted to treat this disease.


Subject(s)
Basophils/metabolism , Cytokines/pharmacology , Eosinophilic Esophagitis/metabolism , Eosinophilic Esophagitis/pathology , Adult , Animals , Antibodies, Monoclonal/pharmacology , Basophils/drug effects , Cytokines/metabolism , Disease Models, Animal , Eosinophils/drug effects , Eosinophils/metabolism , Eosinophils/ultrastructure , Esophagus/drug effects , Esophagus/pathology , Esophagus/ultrastructure , Female , Humans , Immunoglobulin E/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neutralization Tests , Thymic Stromal Lymphopoietin
10.
Nat Biotechnol ; 30(9): 883-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22922673

ABSTRACT

Protection against mucosally transmitted infections probably requires immunity at the site of pathogen entry, yet there are no mucosal adjuvant formulations licensed for human use. Polyethyleneimine (PEI) represents a family of organic polycations used as nucleic acid transfection reagents in vitro and DNA vaccine delivery vehicles in vivo. Here we show that diverse PEI forms have potent mucosal adjuvant activity for viral subunit glycoprotein antigens. A single intranasal administration of influenza hemagglutinin or herpes simplex virus type-2 (HSV-2) glycoprotein D with PEI elicited robust antibody-mediated protection from an otherwise lethal infection, and was superior to existing experimental mucosal adjuvants. PEI formed nanoscale complexes with antigen, which were taken up by antigen-presenting cells in vitro and in vivo, promoted dendritic cell trafficking to draining lymph nodes and induced non-proinflammatory cytokine responses. PEI adjuvanticity required release of host double-stranded DNA that triggered Irf3-dependent signaling. PEI therefore merits further investigation as a mucosal adjuvant for human use.


Subject(s)
Adjuvants, Immunologic/pharmacology , Antigens, Viral/immunology , Immunity, Mucosal/drug effects , Polyethyleneimine/pharmacology , Alum Compounds/pharmacology , Animals , Body Weight , Cell Line , DNA/metabolism , Female , Hemagglutinins, Viral/immunology , Immunity, Mucosal/immunology , Influenza A virus/immunology , Kaplan-Meier Estimate , Mice , Mice, Inbred BALB C , Nasal Mucosa/immunology , Orthomyxoviridae Infections/immunology , Statistics, Nonparametric , Viral Envelope Proteins/immunology , Viral Vaccines/immunology
11.
Vaccine ; 28(13): 2482-9, 2010 Mar 16.
Article in English | MEDLINE | ID: mdl-20132920

ABSTRACT

Carbopol is a polyanionic carbomer gel used in man for a variety of topical applications and drug delivery purposes. Here we show that subcutaneous administration of carbopol with glycoprotein antigens elicits unusually strong specific adaptive immune responses in mice. Recombinant soluble HIV-1 envelope glycoprotein (Env)-based antigen formulated in carbopol was at least as potent at stimulating Env-specific B and T cell responses as Freund's Complete Adjuvant, and significantly more potent than aluminium salts. The antigen-specific T cell immune response elicited both Th1 and Th2 cytokines including high titers of IFN-gamma, IL-2 and IL-4, and drove a Th1 isotype-switched antibody response. Mice immunized with a low dose of purified influenza HA in carbopol generated high titers of anti-HA antibodies and were protected from lethal challenge and disease with live virus. Similarly, immunization of mice with the melanoma cell line B16F10 formulated in carbopol significantly delayed tumor growth. We propose that carbopol, or related cross-linked polyacrylic acid analogues, may have promise for use as systemic vaccine adjuvants in man.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Drug Carriers/administration & dosage , Hemagglutinin Glycoproteins, Influenza Virus/administration & dosage , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Polyvinyls/administration & dosage , env Gene Products, Human Immunodeficiency Virus/administration & dosage , env Gene Products, Human Immunodeficiency Virus/immunology , Acrylic Resins , Animals , Antibodies, Viral/blood , Cancer Vaccines/immunology , Cells, Cultured , Cytokines/metabolism , Female , HIV Antibodies/blood , Injections, Subcutaneous , Male , Melanoma/prevention & control , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Orthomyxoviridae Infections/prevention & control , Th1 Cells/immunology , Th2 Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL